Back
KalVista Pharmaceuticals Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51
KALV
KalVista Pharmaceuticals
Last Price:
9.11
Seasonality Move:
13.48%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.
KalVista Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.65 | Sell |
| 20-day SMA: | 9.73 | Sell |
| 50-day SMA: | 10.83 | Sell |
| 200-day SMA: | 11.89 | Sell |
| 8-day EMA: | 9.58 | Sell |
| 20-day EMA: | 9.9 | Sell |
| 50-day EMA: | 10.56 | Sell |
| 200-day EMA: | 11.42 | Sell |
KalVista Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 42.65 | Sell |
| Chaikin Money Flow: | 86108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.28 - 10.78) | Sell |
| Bollinger Bands (100): | (10.14 - 13.18) | Sell |
KalVista Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for KalVista Pharmaceuticals Stock
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 9.44 while KALV 8-day simple moving average is 9.65, which is a Sell signal.
- The stock price of KALV is 9.44 while KalVista Pharmaceuticals 20-day SMA is 9.73, which makes it a Sell.
- KalVista Pharmaceuticals 50-day simple moving average is 10.83 while KALV share price is 9.44, making it a Sell technically.
- KALV stock price is 9.44 and KalVista Pharmaceuticals 200-day simple moving average is 11.89, creating a Sell signal.
KALV Technical Analysis vs Fundamental Analysis
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy or a Sell?
-
KalVista Pharmaceuticals stock is rated a Buy
The current KalVista Pharmaceuticals [KALV] share price is $9.44. The Score for KALV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
KalVista Pharmaceuticals Stock Info
Market Cap:
466.51M
Price in USD:
9.44
Share Volume:
247.56K
KalVista Pharmaceuticals 52-Week Range
52-Week High:
16.88
52-Week Low:
8.19
Buy
51
KalVista Pharmaceuticals (KALV)
is a Buy
KalVista Pharmaceuticals Share Price Forecast
-
What is the KalVista Pharmaceuticals stock price today?
The KalVista Pharmaceuticals stock price is 9.44 USD today. -
Will KALV stock go up or go down?
KalVista Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is KalVista Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, KalVista Pharmaceuticals is not overvalued.
Is KalVista Pharmaceuticals Stock a Buy?
- KalVista Pharmaceuticals share price is 9.44 while KALV 8-day exponential moving average is 9.58, which is a Sell signal.
- The stock price of KALV is 9.44 while KalVista Pharmaceuticals 20-day EMA is 9.90, which makes it a Sell.
- KalVista Pharmaceuticals 50-day exponential moving average is 10.56 while KALV share price is 9.44, making it a Sell technically.
- KALV stock price is 9.44 and KalVista Pharmaceuticals 200-day simple moving average is 11.42, creating a Sell signal.
Fundamental Analysis of KalVista Pharmaceuticals
Is KalVista Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.40 per share, and a decrease next year of $0.61 per share.
Technical Analysis of KalVista Pharmaceuticals
Should I short KalVista Pharmaceuticals stock?
- KALV Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting KalVista Pharmaceuticals is a Sell
- KalVista Pharmaceuticals Relative Strength Index (RSI) is 42.65, which suggest KalVista Pharmaceuticals is oversold
- The Bollinger Bands (25) for KalVista Pharmaceuticals is (9.28 - 10.78), which suggest KalVista Pharmaceuticals is a Sell
- The Bollinger Bands (100) for KalVista Pharmaceuticals is (10.14 - 13.18), which suggest KalVista Pharmaceuticals is a Sell
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.